Literature DB >> 24078159

Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome.

Amal S El-Shal, Sally M Shalaby, Nader M Aly, Nearmeen M Rashad, Ahmed M Abdelaziz.   

Abstract

Obesity, insulin resistance, and hyperandrogenism are considered crucial parameters of polycystic ovary syndrome (PCOS) which might be related to vitamin D metabolism. The aim of this study was to investigate the associations between polymorphisms (TaqI and ApaI) in the vitamin D receptor gene (VDR) and PCOS among Egyptian women. We aimed also to elucidate the impact of these polymorphisms on vitamin D level, hormonal and metabolic parameters of PCOS. One hundred and fifty Egyptian women with PCOS and 150 unrelated controls were enrolled in this study. Polymorphisms of VDR Taq-I T/C (rs731236) and Apa-I A/C (rs7975232) gene were genotyped using polymerase chain reaction restriction fragment length polymorphism (PCR–RFLP). Serum 25 hydroxy vitamin D [25(OH) D] levels were measured by high-performance liquid chromatography. PCOS women had significantly lower levels of 25(OH) D compared to healthy women. Our results revealed that Taq-I CC genotype and C allele were associated with increased risk of PCOS, while the Apa-I polymorphism was not. Haplotype Taq-I C/ Apa-I C was associated with a higher PCOS risk more than controls. Moreover, there was a significant decrease of 25(OH) D levels in carriers of haplotype Taq-I C/ Apa-I C (with variant alleles) compared to the non-carriers. Results showed also that there was an obesity- VDR Taq-I genotypes interactions. These results suggested that, VDR Taq-I gene polymorphism is associated with increased risk of PCOS in Egyptian women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078159     DOI: 10.1007/s11033-013-2716-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  46 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset.

Authors:  W Z Ye; A F Reis; D Dubois-Laforgue; C Bellanné-Chantelot; J Timsit; G Velho
Journal:  Eur J Endocrinol       Date:  2001-08       Impact factor: 6.664

Review 4.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

5.  Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome.

Authors:  Fariba Ranjzad; Aidin Mahban; Atena Irani Shemirani; Touraj Mahmoudi; Mohsen Vahedi; Abdolrahim Nikzamir; Mohammad Reza Zali
Journal:  J Assist Reprod Genet       Date:  2010-11-17       Impact factor: 3.412

6.  Calcitriol down-modulates the 3,5,3' triiodothyronine (T3) receptors and affects, in a biphasic manner, the T3-dependent adipose differentiation of Ob 17 preadipocytes.

Authors:  C Lenoir; A Dace; C Martin; J Bonne; M Teboul; R Planells; J Torresani
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study.

Authors:  Batool Rashidi; Fedieh Haghollahi; Mamak Shariat; Farid Zayerii
Journal:  Taiwan J Obstet Gynecol       Date:  2009-06       Impact factor: 1.705

9.  Therapeutic potential of the 2-alkyl and 2-alkylidene-19-nor-(20S)-modified analogs of 1alpha,25-dihydroxyvitamin D3.

Authors:  Hector F DeLuca
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

Review 10.  The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators.

Authors:  T Kawada; Y Kamei; E Sugimoto
Journal:  Int J Obes Relat Metab Disord       Date:  1996-03
View more
  19 in total

1.  Genetic variations in the vitamin-D receptor (VDR) gene in preeclampsia patients in the Chinese Han population.

Authors:  Ying Zhan; Mengchun Liu; Yuelan You; Yan Zhang; Jingli Wang; Xunfeng Wang; Shiguo Liu; Xuemei Liu
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  Vitamin D deficiency in women with polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi; Soo Jin Chae; Kyu Ri Hwang; Sang Ho Yoon; Min Jeong Kim; Sun Mie Kim; Seung Yup Ku; Seok Hyun Kim; Jung Gu Kim
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

3.  Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population.

Authors:  Shi-guo Liu; Yuan-yuan Li; Rui-xia Sun; Jing-li Wang; Xin-de Li; Lin Han; Nan Chu; Chang-gui Li
Journal:  Rheumatol Int       Date:  2014-11-07       Impact factor: 2.631

Review 4.  Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D.

Authors:  Alan Sacerdote; Paulomi Dave; Vladimir Lokshin; Gül Bahtiyar
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

Review 5.  Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.

Authors:  Chunla He; Zhoumeng Lin; Sara Wagner Robb; Amara E Ezeamama
Journal:  Nutrients       Date:  2015-06-08       Impact factor: 5.717

6.  VDR Gene variation and insulin resistance related diseases.

Authors:  Fei-Fei Han; Ya-Li Lv; Li-Li Gong; He Liu; Zi-Rui Wan; Li-Hong Liu
Journal:  Lipids Health Dis       Date:  2017-08-19       Impact factor: 3.876

7.  Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bünecker Lecke; Poli Mara Spritzer
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

8.  Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bunecker Lecke; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2018-04-18       Impact factor: 5.211

Review 9.  Potential genetic polymorphisms predicting polycystic ovary syndrome.

Authors:  Yao Chen; Shu-Ying Fang
Journal:  Endocr Connect       Date:  2018-04-05       Impact factor: 3.335

10.  Vitamin D Receptor TaqI Polymorphism Is Associated With Reduced Follicle Number in Women Utilizing Assisted Reproductive Technologies.

Authors:  Mila W Reginatto; Bartira M Pizarro; Roberto A Antunes; Ana C A Mancebo; Luísa Hoffmann; Pâmela Fernandes; Patrícia Areas; Maria I Chiamolera; Rosane Silva; Maria do Carmo Borges de Souza; Enrrico Bloise; Tânia M Ortiga-Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.